Statin medications, known for inducing ferroptosis by restraining the transcriptional expression of PD-L1, mediate an inflammatory tumor microenvironment, thus bolstering anti-PD-1 immunotherapy in NSCLC and unveiling a potential treatment avenue for immune-cold tumors in NSCLC (118). Here, CD274 is linked to non-small cell lung carcinoma.